arrow_back Back to App

Affordable Insulin Act: Lower Costs for Patients

This act aims to reduce insulin costs for individuals covered by Medicare Part D and private health plans. It will lower out-of-pocket expenses for insulin, making essential treatment more accessible and easing the financial burden of diabetes.
Key points
Medicare Part D users will have a maximum monthly insulin cost of $35 starting October 1, 2022.
Private health plans, from January 1, 2023, cannot apply deductibles or charge more than $35 per month for insulin, or 25% of the negotiated price if lower.
Insulin cost-sharing payments will count towards annual deductibles and out-of-pocket maximums.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_S_3700
Sponsor: Sen. Warnock, Raphael G. [D-GA]
Process start date: 2022-02-17
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Affordable Insulin Now Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_S_3700.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2022-02-17.

What are the main provisions?

Key points include:

  • Medicare Part D users will have a maximum monthly insulin cost of $35 starting October 1, 2022.
  • Private health plans, from January 1, 2023, cannot apply deductibles or charge more than $35 per month for insulin, or 25% of the negotiated price if lower.
  • Insulin cost-sharing payments will count towards annual deductibles and out-of-pocket maximums.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Warnock, Raphael G. [D-GA].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

CATEGORIES

Health